Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 156

• Price / Volume Information    Yesterday's Closing Price: $11.02 Daily Weekly Monthly 20 Day Moving Average: 438,678 shares Shares Outstanding: 34.52 (millions) Market Capitalization: $380.43 (millions) Beta: 0.54 52 Week High: $17.35 52 Week Low: $8.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.57% -1.49% 12 Week 22.44% 13.19% Year To Date 9.11% 4.23%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 566 QUEENSBURY AVENUE - QUEENSBURY,NY 12804 USA ph: 518-743-8892 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director John R. Sylvester - Chairman of the Board Sandra Pennell - Chief Financial Officer Elizabeth Czerepak - Director Steven Salamon - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 34.52 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.54 Market Capitalization: $380.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.88 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 1,102.00 PEG Ratio: - Price Ratios Price/Book: 3.38 Price/Cash Flow: 210.81 Price / Sales: 4.21 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: 40.00% Sales Growth vs. Year Ago Period: 26.33% vs. Previous Quarter: 20.58% ROE 03/31/26 - 0.51 12/31/25 - 2.63 09/30/25 - 7.02 ROA 03/31/26 - 0.46 12/31/25 - 2.39 09/30/25 - 6.39 Current Ratio 03/31/26 - 11.24 12/31/25 - 10.92 09/30/25 - 15.06 Quick Ratio 03/31/26 - 10.33 12/31/25 - 9.98 09/30/25 - 13.71 Operating Margin 03/31/26 - 0.62 12/31/25 - 3.17 09/30/25 - 8.13 Net Margin 03/31/26 - 0.62 12/31/25 - 3.17 09/30/25 - 1.50 Pre-Tax Margin 03/31/26 - 1.48 12/31/25 - 4.12 09/30/25 - 1.82 Book Value 03/31/26 - 3.26 12/31/25 - 3.15 09/30/25 - 3.25 Inventory Turnover 03/31/26 - 1.23 12/31/25 - 1.22 09/30/25 - 1.24 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©